EGFR targeted nanoparticle feasibility study (2016–2017)

Grant type:
Samyang Biopharmaceuticals Corporation
Researchers:
  • Emeritus Professor
    Australian Institute for Bioengineering and Nanotechnology
  • Senior Group Leader and Deputy Dire
    Centre for Advanced Imaging
    Australian Institute for Bioengineering and Nanotechnology
    Affiliate PRF & Group Leader
    Australian Institute for Bioengineering and Nanotechnology
  • Advance Qld Industry Res Fellow
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
Samyang Biopharmaceuticals Corporation